価格表

在庫・価格 : 2024年05月07日 19時25分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Glypican 3, Human, Recombinant
データシート
2119-GP-050 RSDアールアンドディー システムス
R&D Systems, Inc.
50 μg ¥98,000 2個 追加

在庫・価格 : 2024年05月07日 19時25分 現在

Glypican 3, Human, Recombinant

  • 商品コード:2119-GP-050
  • メーカー:RSD
  • 包装:50μg
  • 価格: ¥98,000
  • 在庫:2個
使用文献
No. 文献情報 備考 参照
1 Motomura Y et al. Embryonic stem cell-derived dendritic cells expressing glypican-3, a recently identified oncofetal antigen, induce protective immunity against highly metastatic mouse melanoma, B16-F10. Cancer Res. 2006 Feb;66(4):2414-22
Motomura Y et al
2006/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
2 Komori H et al. Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma. Clin. Cancer Res. 2006 May;12(9):2689-97
Komori H et al
2006/01/01
Application: ELISA Standard PubMed
3 Sawada Y et al. Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival. Clin. Cancer Res. 2012 Jul;18(13):3686-96
Sawada Y et al
2012/01/01
Application: ELISA Standard, Sample Type: N/A PubMed
4 Gao W et al. Epitope mapping by a Wnt-blocking antibody: evidence of the Wnt binding domain in heparan sulfate. Sci Rep 2016 May;6:26245
Gao W et al
2016/01/01
Application: ELISA Standard, Sample Type: Cell Culture Supernates PubMed
  • No.: 1
  • 文献情報:
    Motomura Y et al. Embryonic stem cell-derived dendritic cells expressing glypican-3, a recently identified oncofetal antigen, induce protective immunity against highly metastatic mouse melanoma, B16-F10. Cancer Res. 2006 Feb;66(4):2414-22
    Motomura Y et al
    2006/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Komori H et al. Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma. Clin. Cancer Res. 2006 May;12(9):2689-97
    Komori H et al
    2006/01/01
  • 備考:
    Application: ELISA Standard
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Sawada Y et al. Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival. Clin. Cancer Res. 2012 Jul;18(13):3686-96
    Sawada Y et al
    2012/01/01
  • 備考:
    Application: ELISA Standard, Sample Type: N/A
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Gao W et al. Epitope mapping by a Wnt-blocking antibody: evidence of the Wnt binding domain in heparan sulfate. Sci Rep 2016 May;6:26245
    Gao W et al
    2016/01/01
  • 備考:
    Application: ELISA Standard, Sample Type: Cell Culture Supernates
  • 参照:
    PubMed